| Trial ID: | L3116 |
| Source ID: | NCT00517465
|
| Associated Drug: |
Placebo
|
| Title: |
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Placebo|DRUG: RG1511
|
| Outcome Measures: |
Primary: AEs, laboratory parameters, vital signs., Throughout study|Glucose AUC, Days -1, 1 and 8. | Secondary: Insulin, C-peptide, glucagon and GLP-1 AUC, Days -1, 1 and 8|24h glucose, Days -1, 1 and 8|Lipid profiles, Days -1 and 8|Pharmacokinetic parameters, Days 1 and 8
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
41
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-09
|
| Completion Date: |
2009-03
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-02
|
| Locations: |
Berlin, 14050, Germany|Neuss, 41460, Germany|Balatonfuered, 8230, Hungary|Budapest, 1027, Hungary|Bratislava, 82108, Slovakia|Bratislava, 833 05, Slovakia|Slough, SL1 4AA, United Kingdom|Welwyn Garden City, AL7 1TW, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00517465
|
